Karma Biotechnologies
Karma is a proud IndieBio company! We're thrilled to be in the current IBSF14 cohort. Metastatic cancer can be cured by cytokine immunotherapies, but only for a lucky few (about 7% of patients). Karma is making these medicines safe and effective for the other 93% by engineering immune cells to manufacture cytokines and other biologicals locally within the tumor, exactly where they're needed.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
2
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
42
organic / mo
Sign up free to see all 1 verified contacts at Karma Biotechnologies
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
Showing 1 of 1 verified contacts
Top roles at Karma Biotechnologies
1 distinct titles indexed · top 1 shown.
- 1associate director
Sign up to unlock all 1 contacts at Karma Biotechnologies
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Karma Biotechnologies
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.